BioLine RX Ltd Share Price Today: Live Updates & Key Insights

BioLine RX Ltd share price today is $2.65, up -2.19%. The stock opened at $2.75 against the previous close of $2.7094, with an intraday high of $2.75 and low of $2.75.

BioLine RX Ltd Share Price Chart

BioLine RX Ltd

us-stock
To Invest in {{usstockname}}
us-stock

BioLine RX Ltd Share Price Performance

$2.65 -0.0219(-2.19%) BLRX at 23 Mar 2026 12:15 PM Biotechnology
Lowest Today 2.75
Highest Today 2.75
Today’s Open 2.75
Prev. Close 2.7094
52 Week High 7.77
52 Week Low 2.30
Day’s Range: Low 2.75 High 2.75
52-Week Range: Low 2.30 High 7.77
1 day return -
1 Week return -
1 month return -5.86
3 month return -5.53
6 month return -29.45
1 year return -18.26
3 year return +259.21
5 year return -9.9
10 year return -

BioLine RX Ltd Institutional Holdings

Citadel Advisors Llc 0.84

UBS Group AG 0.15

Morgan Stanley - Brokerage Accounts 0.14

Rhumbline Advisers 0.08

Fidelity Nasdaq Composite Index 0.04

Wells Fargo & Co 0.04

BNP Paribas Arbitrage, SA 0.03

Goss Wealth Management LLC 0.00

Advisor Group Holdings, Inc. 0.00

Rockefeller Capital Management L.P. 0.00

ACT Capital Management, LLC 0.00

Bank of America Corp 0.00

Citigroup Inc 0.00

Danske Bank A/S. 0.00

Fifth Third Bancorp 0.00

NATIONAL BANK OF CANADA /FI/ 0.00

SBI Securities Co Ltd 0.00

SIMPLEX TRADING, LLC 0.00

Susquehanna International Group, LLP 0.00

Tower Research Capital LLC 0.00

TWO SIGMA SECURITIES, LLC 0.00

BioLine RX Ltd Market Status

Strong Buy: 1

Buy: 1

Hold: 0

Sell: 0

Strong Sell: 0

BioLine RX Ltd Fundamentals

Market Cap 15.18 M

PB Ratio 0.5903

PE Ratio 0.0

Enterprise Value -2.05 M

Total Assets 38.91 M

Volume 9149

BioLine RX Ltd Company Financials

Annual Revenue FY23:0 0.0M, FY22:0 0.0M, FY21:0 0.0M, FY20:0 0.0M, FY19:0 0.0M

Annual Profit FY23:null 0.0M, FY22:null 0.0M, FY21:null 0.0M, FY20:null 0.0M, FY19:null 0.0M

Annual Net worth FY23:-52461000 -52.5M, FY22:-18872000 -18.9M, FY21:-28144000 -28.1M, FY20:-30932000 -30.9M, FY19:-26806000 -26.8M

Quarterly Revenue Q3/2025:427000 0.4M, Q2/2025:304000 0.3M, Q1/2025:255000 0.3M, Q3/2024:4943000 4.9M, Q2/2024:5393000 5.4M

Quarterly Profit Q3/2025:343000 0.3M, Q2/2025:232000 0.2M, Q1/2025:221000 0.2M, Q3/2024:4121000 4.1M, Q2/2024:4496000 4.5M

Quarterly Net worth Q3/2025:-977000 -1.0M, Q2/2025:-3940000 -3.9M, Q1/2025:5127000 5.1M, Q3/2024:-5822000 -5.8M, Q2/2024:484000 0.5M

About BioLine RX Ltd & investment objective

Company Information BioLineRx Ltd., a commercial stage biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases. The company's pipeline includes APHEXDA (motixafortide), a peptide that is in Phase 1 clinical trial for the treatment of sickle cell disease, and Phase 2b clinical trial for the treatment of pancreatic cancer, as well as completed Phase 3 clinical trial for the treatment of multiple myeloma. It develops BL-5010, a pen-like applicator containing an acidic aqueous solution for the non-surgical removal of skin lesions. BioLineRx Ltd. was incorporated in 2003 and is headquartered in Hevel Modi'in, Israel.

Organisation Biotechnology

Employees 28

Industry Biotechnology

CEO null

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

BioLine RX Ltd FAQs

What is the share price of BioLine RX Ltd today?

The current share price of BioLine RX Ltd is $2.65.

Can I buy BioLine RX Ltd shares in India?

Yes, Indian investors can buy BioLine RX Ltd shares by opening an international trading and demat account with Motilal Oswal.

How to buy BioLine RX Ltd shares in India?

You can easily invest in BioLine RX Ltd shares from India by:

Can I buy fractional shares of BioLine RX Ltd?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of BioLine RX Ltd?

BioLine RX Ltd has a market cap of $15.18 M.

In which sector does BioLine RX Ltd belong?

BioLine RX Ltd operates in the Biotechnology sector.

What documents are required to invest in BioLine RX Ltd stocks?

To invest, you typically need:

What is the PE and PB ratio of BioLine RX Ltd?

The PE ratio of BioLine RX Ltd is N/A and the PB ratio is 0.59.